Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life

Pediatric Hematology and Oncology

Volumn 15, Issue 5, 1998, Pages 415-420

  Testa, Marcella ^a,b   Reali, Alessandra ^a   Copula, Maristella ^a   Pinna, Bernadette ^a   Birocchi, Francesca ^a   Pisu, Cinzia ^a   Chiappe, Francesco ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Ospedale   (Italy)

Author keywords

Anemia; Preterm; rHuEpo; Transfusion

Indexed keywords

ALPHA TOCOPHEROL; FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; IRON BLOOD LEVEL; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; NEWBORN ANEMIA; NEWBORN INTENSIVE CARE; ORAL DRUG ADMINISTRATION; PREMATURITY; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031688488     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019809016569     Document Type: Article

References (21)

1. Halpérin D, Wacker P, Lacomt G, et al. Effects of recombinant erythropoietin in infants with anemia of prematurity: a pilot study. J Pediatr. 1990;116:779-780.
2. Shannon KM, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr. 1991;118:949-955.
3. Obladen M, Maier R, Segerer H, et al. Efficacy and safety of recombinant human erythropoietin to prevent the anemia of prematurity. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L, eds. Erythropoietin in Renal and Non-Renal Anemias. Basel: Karger; 1991:314-326; Contrib Nephrol. 88.
4. Obladen M, Maier R, Segerer H, et al. Efficacy and safety of recombinant human erythropoietin to prevent the anemia of prematurity. In: Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L, eds. Erythropoietin in Renal and Non-Renal Anemias. Basel: Karger; 1991:314-326; Contrib Nephrol. 88.
5. Ohls R, Christensen R. Recombinant erythropoietin compare with erythrocite transfusion in the treatment of the anemia of prematurity. J Pediatr. 1991;119:781-788.
6. Shannon KM, Mentzer WC, Abels RI, et al. Enhancement of erythropoiesis by recombinant erythropoietin in low birth weight infants: a pilot study. J Pediatr. 1992;120:586-592.
7. Carnielli V, Montini G, Da Riol R, Dall'Amico R, Gantarutti F. Effects of high doses of human recombinant erythropoietin on the need for blood transfusions in the preterm infants. J Pediatr. 1992;121: 98-102.
8. Emmerson A, Coles H, Stern C, Pearson T. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child. 1993;63:291-296.
9. MesserJ, Haddad J, Donato I, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics. 1992;92:519-523.
10. Bechensteen AG, Haya P, Halvorsen S, et al. Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child. 1993;69:19-23.
11. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study. Pediatr Res. 1993;34:675-679.
12. Halpérin D, Felix M, Wacker P, Lacourt G, Babel J, Wyss M. Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr. 1992;151:661-667.
13. Maier RF, Obladen M, Scigalla P, et al. The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med. 1994;330:1173-1178.
14. Meyer MP, Meyer JH, Commerford A, et al. Recombinant human erythropoietin in treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics. 1994;93:918-923.
15. Obladen M, Sachsenwenger M, Stahkne M. Blood sampling in VLBW infants receiving different levels of intensive care. Eur J Pediatr. 1988;147:399-404.
16. Sabio H. Anaemia in the high risk infant. Clin Perinatol 1984;11:59-72.
17. Nexo E, Christensen NC, Olesen H. Volume of blood removed for analytical purposes during hospitalisation of VLBW infants. Clin Chem. 1981;27:759-761.
18. Halpérin D. Use of recombinant erythropoietin in treatment of the anemia of prematurity. Am J Pediatr Hematol Oncol. 1991;13:351-363.
19. Brown MS, Berman ER, Luckey D. Prediction of the need for transfusion during anaemia of prematurity. J Pediatr. 1990;116:773-778.
20. Wood A, Wilson N, Skacel P, Thomas R, Tidmarsh E Yale C, et al. Reducing donor exposure in preterm infants requiring multiple blood transfusions. Arch Dis Child. 1995;72:F29-F33.
21. Williamson P, Griffiths G, Worfolk D, Levene M. Blood transfusions and human recombinant erythropoietin in premature newborn infants. Arch Dis Child. 1996;75:65-68.